PACS vs. ENSG, NHC, RDNT, PRGO, ALKS, DOCS, ALPN, TMDX, IMVT, and MDGL
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include The Ensign Group (ENSG), National HealthCare (NHC), RadNet (RDNT), Perrigo (PRGO), Alkermes (ALKS), Doximity (DOCS), Alpine Immune Sciences (ALPN), TransMedics Group (TMDX), Immunovant (IMVT), and Madrigal Pharmaceuticals (MDGL). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and The Ensign Group (NASDAQ:ENSG) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, profitability, valuation, risk, earnings, media sentiment and dividends.
In the previous week, PACS Group had 20 more articles in the media than The Ensign Group. MarketBeat recorded 30 mentions for PACS Group and 10 mentions for The Ensign Group. The Ensign Group's average media sentiment score of 1.09 beat PACS Group's score of 0.22 indicating that The Ensign Group is being referred to more favorably in the news media.
The Ensign Group received 341 more outperform votes than PACS Group when rated by MarketBeat users. However, 100.00% of users gave PACS Group an outperform vote while only 66.10% of users gave The Ensign Group an outperform vote.
The Ensign Group has higher revenue and earnings than PACS Group.
96.1% of The Ensign Group shares are held by institutional investors. 3.9% of The Ensign Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
The Ensign Group has a net margin of 5.67% compared to PACS Group's net margin of 0.00%. The Ensign Group's return on equity of 17.60% beat PACS Group's return on equity.
PACS Group currently has a consensus price target of $31.00, indicating a potential upside of 9.89%. The Ensign Group has a consensus price target of $124.60, indicating a potential upside of 4.02%. Given PACS Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe PACS Group is more favorable than The Ensign Group.
Summary
The Ensign Group beats PACS Group on 8 of the 13 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PACS Group Competitors List
Related Companies and Tools
